Islamabad, Sep 26: In honor of World Contraception Day 2024, Bayer Pakistan and the Association for Mothers & Newborns (AMAN) pledged to work together, bringing their combined knowledge and experience to bear in educating Pakistan’s populace about contemporary contraceptive methods and their safe application.
The first of several scheduled scientific sessions for doctors to be held across the nation to raise awareness on how modern contraceptive techniques can help to women’s wellbeing and child health took place after an agreement signing ceremony between the two parties.
World Contraception Day (WCD), which is observed worldwide and is backed by a coalition of multinational organizations, including Bayer, emphasizes the critical role that informed decision-making plays in lowering the number of unwanted births in a world where many women have little control over their reproductive health.
This is particularly pertinent to Pakistan, where around 19 million women between the ages of 15 and 49 say they would prefer not to become pregnant unintentionally. Of them, 9.5 million women, or 50%, lack access to contemporary contraceptives.
Leading research group on reproductive health, the Guttmacher Institute, estimates that there are about 3.7 million unwanted pregnancies in Pakistan each year, of which 2.2 million (or 61% of total) terminate in an induced abortion.
Unwanted pregnancies have a detrimental effect on women’s health since they frequently result in risky medical procedures and exacerbate financial difficulties for families. Therefore, improving access to contemporary contraception is essential to reducing these problems.
Speaking at the event was Khurram Mirza, Country Commercial Lead, Pharmaceutical Division, Bayer Pakistan. He stated: “Our WCD collaboration with AMAN is well-aligned with both the company’s focus on women’s healthcare and Bayer’s global mission, Health for All, Hunger for None.” Women’s health is ingrained in Bayer’s DNA. As a market leader in this area, the company provides a variety of contraceptive methods in addition to treatments for gynecological disorders and menopause management.
Additionally, Bayer plans to sponsor capacity-building initiatives and guarantee the availability of reasonably priced modern contraceptives in order to give 100 million women in low- and middle-income countries access to family planning by 2030.
The Vice President of AMAN, Prof. Dr. Sadiah Ahsan Pal, stated, “The primary health priority in Pakistan is family planning.” It is essential to the advancement of our country. not compelled, but voluntarily. The future health of a family is largely dependent on the midwife, doctor, nurse, LHV, LHW, or other healthcare provider who delivers a healthy baby. They are a source of eternal gratitude and inspiration for that family. We ought to provide them with appropriate family planning advice and help them make wise decisions to avoid unintended pregnancies.
If we execute this well, we will significantly contribute to the positive development of our country. In order to assist women and families throughout Pakistan, Bayer Pakistan and AMAN are hopeful that this symposium series will spark a larger discussion about the critical necessity of expanding access to contemporary contraceptive techniques in the healthcare community and beyond.
